China NMPA Product Recall - Bone cement tools

The National Medical Products Administration (NMPA) announced on May 22, 2023, a Class II voluntary recall initiated by DePuy Ireland UC. This recall, reported by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., targets specific batches of bone cement tools (Bone Cement Instrun, Note 20172046782). The primary concern is that three batches of hip revision connectors, integral components of these tools, did not undergo the required sterilization process. This critical manufacturing oversight presents potential safety risks to patients. Consequently, DePuy Ireland UC, the manufacturer, is executing this voluntary recall to address the non-sterilization issue. A Class II recall signifies that product use or exposure could lead to temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. The NMPA, as the governing regulatory body, oversees such actions to ensure medical devices adhere to safety and quality standards. Further details regarding the affected product models, specifications, and batch numbers are provided in an attached 'Medical Device Recall Event Report Form' from Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. This measure is crucial for mitigating potential patient harm and upholding public health standards.